about
Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse ModelImproved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse ModelColor-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgeryA simple biological imaging system for detecting viable human circulating tumor cells.Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patientsBiological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transferClinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instabilityA case of right-sided Bochdalek hernia incidentally diagnosed in a gastric cancer patientEfficacy of a Cell-Cycle Decoying Killer Adenovirus on 3-D GelfoamĀ®-Histoculture and Tumor-Sphere Models of Chemo-Resistant Stomach Carcinomatosis Visualized by FUCCI Imaging.Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse modelsExperimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.Iron depletion enhances the effect of sorafenib in hepatocarcinomaStrategic approach to concurrent aberrant left gastric vein and aberrant left hepatic artery in laparoscopic distal gastrectomy for early gastric cancer: A case report.Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.Synergistic interaction of telomerase-specific oncolytic virotherapy and chemotherapeutic agents for human cancer.Advances in adenovirus-mediated p53 cancer gene therapy.OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging.Enhanced Metastatic Recurrence Via Lymphatic Trafficking of a High-Metastatic Variant of Human Triple-Negative Breast Cancer After Surgical Resection in Orthotopic Nude Mouse Models.Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics.A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.p53 Replacement Therapy for Cancer.A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas.Preclinical evaluation of differentially targeting dual virotherapy for human solid cancer.A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy.Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus.Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.Portal/splenic vein thrombosis following splenectomy in gastric cancer surgery.ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma.
P50
Q27321510-C41D0A19-5B87-4723-AA38-4545F36ED771Q27322712-D6951AC9-7695-44A2-9F40-843337DF065CQ27325828-1B28CF74-C8BE-4D46-8650-9345F426BBA3Q30490534-16E848E7-2D5B-446D-913D-136300FD9CE1Q30724810-D822F7BA-BBB3-425F-BC43-AA7F521AEAC0Q34750564-C45A684F-8493-4500-9D3F-A73AFD390279Q35153125-65C334F3-B466-4113-AA4B-9081B739E7CDQ35596426-DF954008-FDC9-4D6C-B5C3-93FA8FF5C105Q35677409-F16A62C3-2602-489C-A75D-547A353E0E2AQ35857476-2727666D-B90E-495F-BB6C-B9D4271D9D93Q35881121-6549A865-431C-4846-9B22-455167FE75C4Q36035186-09A22F3E-5F57-4064-BA7B-93BA55EB6341Q36145816-5980BB38-89D5-43FC-9C4E-8DA36D146C6CQ36198088-5B48242C-638F-4610-B90C-DEF477EEEBDFQ36756809-2950D322-0B12-4EF2-AC89-7E5D91B1D530Q37054272-C257CE1E-2730-49A8-B8C1-13A8F792F56BQ37109813-CCFF6CAA-81EF-47BE-B51C-80D2B7B97E73Q37187753-7773ED34-6538-4879-97A4-872C14606696Q37340442-F4B4622E-0A66-47A0-AA78-42FEF04891D0Q37688996-45E7BABF-1E23-481C-A7C7-70CDA8822C91Q37866781-DFD5C195-B74A-4097-9434-5A6D9478A7C0Q37899233-092433D8-CAEC-4B4A-8C88-9CF90ED0CDC0Q38150910-6CE781B9-A353-43B4-BFF1-F07136878105Q38720403-592A867A-36F7-4AA5-8C36-59146A246BEFQ38724598-F9A327EA-8DDF-40D8-ACA2-93E8A638D6B7Q38727532-BEED0B69-11F0-4064-A8C2-60AE07A9995CQ38742078-9264802A-12E9-4E7D-97D0-A3E78CE47294Q38746421-7AE17C0F-B5F0-41F4-A236-27601353B38AQ38990791-877494AC-6AE2-48B3-A236-679E6AEC0ADBQ39089458-5A7A1147-3CD6-4998-8E7B-ECE0B1AD6869Q39094425-684AD1B2-8DAB-4C92-8411-E19C0846B0A1Q39413029-B0DE3DF8-57C3-4382-925F-6A4B755E950AQ39591333-71554FD8-1164-4079-AAFD-8DA07E339CC2Q39700474-8B279CFB-3772-4CB9-A70A-441658E4493EQ39771175-43B10149-147E-4AE8-94C1-D4FBEAB4EB6DQ40002832-D8806A37-D6F1-4214-9D04-77A8BD387E09Q40024248-A5CF7B46-624F-4F98-A8DB-D62E31020DA9Q40316523-AD7A7BC9-6B31-44DC-A1D1-335008239210Q40331902-8E39AEFC-3EB4-4014-9513-19CC0691BB9CQ40397259-9521E238-16C5-4FCE-A7A3-75489A70A1CF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
Õ°Õ„ÕæÕ”Õ¦ÕøÕæÕøÕ²
@hy
name
Shunsuke Kagawa
@ast
Shunsuke Kagawa
@en
Shunsuke Kagawa
@es
Shunsuke Kagawa
@nl
Shunsuke Kagawa
@sl
type
label
Shunsuke Kagawa
@ast
Shunsuke Kagawa
@en
Shunsuke Kagawa
@es
Shunsuke Kagawa
@nl
Shunsuke Kagawa
@sl
prefLabel
Shunsuke Kagawa
@ast
Shunsuke Kagawa
@en
Shunsuke Kagawa
@es
Shunsuke Kagawa
@nl
Shunsuke Kagawa
@sl
P106
P1153
7202593022
P21
P31
P496
0000-0002-3610-8211
P569
2000-01-01T00:00:00Z